Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.
第一作者:
P,Macor
第一单位:
Department of Life Sciences, University of Trieste, Trieste, Italy.
作者:
主题词
动物(Animals);抗体(Antibodies);抗体, 双特异性(Antibodies, Bispecific);抗体依赖细胞细胞毒性(Antibody-Dependent Cell Cytotoxicity);抗原, CD20(Antigens, CD20);伯基特淋巴瘤(Burkitt Lymphoma);细胞分离(Cell Separation);克隆, 分子(Cloning, Molecular);补体系统蛋白质类(Complement System Proteins);疾病模型, 动物(Disease Models, Animal);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);流式细胞术(Flow Cytometry);人类(Humans);免疫疗法(Immunotherapy);杀伤细胞, 天然(Killer Cells, Natural);巨噬细胞(Macrophages);小鼠(Mice);小鼠, SCID(Mice, SCID);显微镜检查, 荧光(Microscopy, Fluorescence)
DOI
10.1038/leu.2014.185
PMID
24903480
发布时间
2021-10-21
- 浏览16

Leukemia
406-14页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文